Cargando…

Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature

The COVID-19 outbreak was declared a pandemic on March 2020. Many patients with SARS-CoV-2 infection have underlying chronic medical conditions such as diabetes, cardiovascular disease (CVD), and hypertension. Patient-related outcomes are worse if there are associated comorbidities. We do not have e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahimi, Leili, Malek, Mojtaba, Ismail-Beigi, Faramarz, Khamseh, Mohammad E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338141/ https://www.ncbi.nlm.nih.gov/pubmed/32632851 http://dx.doi.org/10.1007/s12325-020-01417-8

Ejemplares similares

Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial
por: Attaran, Fereshte, et al.
Publicado: (2023)

A View Beyond HbA1c: Role of Continuous Glucose Monitoring
por: Chehregosha, Haleh, et al.
Publicado: (2019)

Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Taheri, Hoda, et al.
Publicado: (2020)

Glucocorticoid-Induced Fatty Liver Disease
por: Rahimi, Leili, et al.
Publicado: (2020)

Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study
por: Hashemi Madani, Nahid, et al.
Publicado: (2020)

Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Chehrehgosha, Haleh, et al.
Publicado: (2021)

SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions
por: Gharaibeh, Naser Eddin, et al.
Publicado: (2019)

Risk of Cancer in Diabetes: The Effect of Metformin
por: Malek, Mojtaba, et al.
Publicado: (2013)

Prehypertension; patient awareness and associated cardiovascular risk factors in an urban population in Iran
por: Badakhsh, Mohammad Hossein, et al.
Publicado: (2015)

Alteration of pulmonary function in diabetic nephropathy
por: Shafiee, Gita, et al.
Publicado: (2013)

The Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Body Composition in Type 2 Diabetes Mellitus: A Narrative Review
por: Jahangiri, Soodeh, et al.
Publicado: (2023)

Diabetic Retinopathy, Its Progression, and Incident Cardiovascular Events in the ACCORD Trial
por: Gerstein, Hertzel C., et al.
Publicado: (2013)

Issues and challenges in diabetic neuropathy management: A narrative review
por: Ismail, Che Aishah Nazariah
Publicado: (2023)

Structured self monitoring of blood glucose in Iranian people with type 2 diabetes; A cost consequence analysis
por: Aghili, Rokhsareh, et al.
Publicado: (2012)

The Mechanism of the Calorigenic Action of Thyroid Hormone : Stimulation of Na(+) + K(+)-activated adenosinetriphosphatase activity
por: Ismail-Beigi, Faramarz, et al.
Publicado: (1971)

Beta‐cell function in type 2 diabetes (T2DM): Can it be preserved or enhanced?
por: Sayyed Kassem, Laure, et al.
Publicado: (2023)

Body composition in adults with newly diagnosed type 2 diabetes: effects of metformin
por: Aghili, Rokhsareh, et al.
Publicado: (2014)

Dry eye disease in type 2 diabetes mellitus; comparison of the tear osmolarity test with other common diagnostic tests: a diagnostic accuracy study using STARD standard
por: Najafi, Laily, et al.
Publicado: (2015)

Comparison of the CES-D and PHQ-9 depression scales in people with type 2 diabetes in Tehran, Iran
por: Khamseh, Mohammad E, et al.
Publicado: (2011)

Determinants of Weight Gain in the Action to Control Cardiovascular Risk in Diabetes Trial
por: Fonseca, Vivian, et al.
Publicado: (2013)

Prolonged Exposure to Insulin Inactivates Akt and Erk(1/2) and Increases Pancreatic Islet and INS1E β-Cell Apoptosis
por: Rachdaoui, Nadia, et al.
Publicado: (2018)

Toe-brachial index is beyond a peripheral issue in patients with type 2 diabetes
por: Darban Hosseini Amirkhiz, Gisoo, et al.
Publicado: (2021)

Gestational diabetes mellitus: Major risk factors and pregnancy-related outcomes: A cohort study
por: Kouhkan, Azam, et al.
Publicado: (2021)

The Relationship between insulin variable number of tandem repeats (INS-VNTR) -23 A/T and cytotoxic Tlymphocyte associated protein-4 (CTLA-4) +49 A/G polymorphisms with islet autoantibodies in persons with diabetes
por: Khoshroo, Mohammad, et al.
Publicado: (2017)

Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review
por: Maghsoomi, Zohreh, et al.
Publicado: (2021)

The Impact of Adding Prandial Insulin to a Basal Based Regimen with Insulin Glargine in Type 2 Diabetic Patients
por: Khamseh, Mohammad Ebrahim, et al.
Publicado: (2021)

SAT-483 Levothyroxine Absorption Test: A Potential Therapeutic Tool for Levothyroxine Malabsorption
por: Arora, Tanureet, et al.
Publicado: (2020)

A survey of clinical practice patterns in diagnosis and management of Cushing's disease in Iran
por: Malek, Mojtaba, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease and compromised endothelial function in people with type 2 diabetes
por: Montazeri, Zeinab, et al.
Publicado: (2023)

The current issues and challenges in the management of floating knee injury: a retrospective study
por: Kenmegne, Guy Romeo, et al.
Publicado: (2023)

The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM)
por: Soltanieh, Samira, et al.
Publicado: (2023)

Huanglongbing Pandemic: Current Challenges and Emerging Management Strategies
por: Ghosh, Dilip, et al.
Publicado: (2022)

Study rationale and design of a study of EMPAgliflozin’s effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial
por: Gohari, Sepehr, et al.
Publicado: (2021)

Emphysematous cystitis: review of current literature, diagnosis and management challenges
por: Fumeo, Martina, et al.
Publicado: (2019)

Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A(1)chieve study
por: Litwak, Leon, et al.
Publicado: (2013)

Identifying specific social challenges of rare diseases: current challenges and issues
por: Dan, Dorica, et al.
Publicado: (2014)

Bioactive Foods and Medicinal Plants for Cardiovascular Complications of Type II Diabetes: Current Clinical Evidence and Future Perspectives
por: Bahramsoltani, Roodabeh, et al.
Publicado: (2021)

Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
por: Calles-Escandón, Jorge, et al.
Publicado: (2010)

Prediction and Prevention of Postpolypectomy Bleeding: Current Challenging Issues
por: Kim, Duck-Woo
Publicado: (2014)

Laboratory Diagnosis of COVID-19: Current Issues and Challenges
por: Tang, Yi-Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0chla26qoc8a4tgctj2rqf5chu